Insights

Loading spinner
Gathering insights about NewBridge Pharmaceuticals

Similar companies to NewBridge Pharmaceuticals

NewBridge Pharmaceuticals Tech Stack

NewBridge Pharmaceuticals uses 8 technology products and services including cdnjs, jQuery CDN, Cloudflare, and more. Explore NewBridge Pharmaceuticals's tech stack below.

  • cdnjs
    Content Delivery Network
  • jQuery CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Google Maps
    Maps
  • Yoast SEO
    Search Engines

Media & News

NewBridge Pharmaceuticals's Email Address Formats

NewBridge Pharmaceuticals uses at least 1 format(s):
NewBridge Pharmaceuticals Email FormatsExamplePercentage
First.Last@nbpharma.comJohn.Doe@nbpharma.com
86%
First@nbpharma.comJohn@nbpharma.com
8%
F-Last@nbpharma.comJ-Doe@nbpharma.com
3%
First.Middle@nbpharma.comJohn.Michael@nbpharma.com
3%

Frequently Asked Questions

Where is NewBridge Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's main headquarters is located at Dubai Science Park North Tower, 17th Floor Dubai, Dubai 500618 AE. The company has employees across 5 continents, including AsiaAfricaNorth America.

What is NewBridge Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact NewBridge Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is NewBridge Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's official website is nbpharma.com and has social profiles on LinkedIn.

How much revenue does NewBridge Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of November 2024, NewBridge Pharmaceuticals's annual revenue reached $35M.

What is NewBridge Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does NewBridge Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of November 2024, NewBridge Pharmaceuticals has approximately 248 employees across 5 continents, including AsiaAfricaNorth America. Key team members include Vice President & General Manager: T. S.Head Of Marketing Rare Disease Franchise: A. B.Head Of Marketing Mena - Immunology: N. L.. Explore NewBridge Pharmaceuticals's employee directory with LeadIQ.

What industry does NewBridge Pharmaceuticals belong to?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does NewBridge Pharmaceuticals use?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's tech stack includes cdnjsjQuery CDNCloudflareTwitter Emoji (Twemoji)Font AwesomejQueryGoogle MapsYoast SEO.

What is NewBridge Pharmaceuticals's email format?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals's email format typically follows the pattern of . Find more NewBridge Pharmaceuticals email formats with LeadIQ.

How much funding has NewBridge Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of November 2024, NewBridge Pharmaceuticals has raised $48M in funding. The last funding round occurred on May 29, 2013 for $48M.

When was NewBridge Pharmaceuticals founded?

Minus sign iconPlus sign icon
NewBridge Pharmaceuticals was founded in 2010.
NewBridge Pharmaceuticals

NewBridge Pharmaceuticals

Pharmaceutical ManufacturingDubai, United Arab Emirates201-500 Employees

NewBridge Pharmaceuticals is a regional specialty company established to bridge the access gap and partner with pharma & biotech companies to in-license and commercialize FDA or EMA/European approved innovative pharmaceutics, biologics, & other healthcare solutions in the Middle East and Africa region. 

The areas of Oncology, Immunology, Neuroscience, Gastrointestinal & Nutrition are NewBridge’s current strategic focus. The existing product portfolio was built to address unmet medical needs in the region & enabled the company not just to gain substantial presence, but also to help patients gain access to these much-needed innovations.

NewBridge is driven by highly experienced leadership in the biopharmaceutical industry regionally & globally, as well as talented motivated teams with a proven track record of regional achievements, which collectively has allowed NewBridge to establish itself as a strategic & successful pharmaceutical partner  of choice in the MENA Region.

NewBridge offers flexible partnership opportunities & best practices in the areas of commercial, regulatory, and medical affairs striving for quality performance & high standards of compliance that pharmaceutical companies look for in a partner to serve as an extension of their practices & values in local markets.

NewBridge is well backed by strong institutional & corporate investors who provide us with the extensive life science network & diverse investment expertise needed to achieve our vision & build  a platform of successful alliances in the region, and create value in an innovative business approach.

This integrated strategy of regional expertise & strong global business network position NewBridge uniquely as an institutional one-stop-solution for our partners in its offering & as a preferred partner-of-choice for the biopharmaceutical & other healthcare companies seeking multi-country access in Middle East and Africa   with its growing economies, yet complex regulations & access hurdles.

Section iconCompany Overview

Headquarters
Dubai Science Park North Tower, 17th Floor Dubai, Dubai 500618 AE
Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
201-500

Section iconFunding & Financials

  • $48M

    NewBridge Pharmaceuticals has raised a total of $48M of funding over 2 rounds. Their latest funding round was raised on May 29, 2013 in the amount of $48M.

  • $10M$50M

    NewBridge Pharmaceuticals's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $48M

    NewBridge Pharmaceuticals has raised a total of $48M of funding over 2 rounds. Their latest funding round was raised on May 29, 2013 in the amount of $48M.

  • $10M$50M

    NewBridge Pharmaceuticals's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.